BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27702652)

  • 1. Prolyl hydroxylase domain enzymes and their role in cell signaling and cancer metabolism.
    Nguyen TL; Durán RV
    Int J Biochem Cell Biol; 2016 Nov; 80():71-80. PubMed ID: 27702652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles and signaling pathways of prolyl-4-hydroxylase 2 in the tumor microenvironment.
    Li A; Zhang Y; Wang Z; Dong H; Fu N; Han X
    Chem Biol Interact; 2019 Apr; 303():40-49. PubMed ID: 30817904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Knockdown and Pharmacologic Inhibition of Hypoxia-Inducible Factor (HIF) Hydroxylases.
    Pickel C; Taylor CT; Scholz CC
    Methods Mol Biol; 2018; 1742():1-14. PubMed ID: 29330785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-Inducible Factor α and Hif-prolyl Hydroxylase Characterization and Gene Expression in Short-Time Air-Exposed Mytilus galloprovincialis.
    Giannetto A; Maisano M; Cappello T; Oliva S; Parrino V; Natalotto A; De Marco G; Barberi C; Romeo O; Mauceri A; Fasulo S
    Mar Biotechnol (NY); 2015 Dec; 17(6):768-81. PubMed ID: 26277612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of hypoxia-inducible factor prolyl hydroxylase domain oxygen sensors: tricking the body into mounting orchestrated survival and repair responses.
    Rabinowitz MH
    J Med Chem; 2013 Dec; 56(23):9369-402. PubMed ID: 23977883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The PHD1 oxygen sensor in health and disease.
    Kennel KB; Burmeister J; Schneider M; Taylor CT
    J Physiol; 2018 Sep; 596(17):3899-3913. PubMed ID: 29435987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolyl hydroxylase mediated inhibition of fatty acid synthase to combat tumor growth in mammary gland carcinoma.
    Singh M; Devi U; Roy S; Gupta PS; Saraf SA; Kaithwas G
    Breast Cancer; 2016 Nov; 23(6):820-829. PubMed ID: 26951539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The non-canonical functions of HIF prolyl hydroxylases and their dual roles in cancer.
    Yu M; Lun J; Zhang H; Zhu L; Zhang G; Fang J
    Int J Biochem Cell Biol; 2021 Jun; 135():105982. PubMed ID: 33894356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel roles of hypoxia response system in glucose metabolism and obesity.
    Ichiki T; Sunagawa K
    Trends Cardiovasc Med; 2014 Jul; 24(5):197-201. PubMed ID: 24774124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic targeting of the HIF oxygen-sensing pathway: Lessons learned from clinical studies.
    Haase VH
    Exp Cell Res; 2017 Jul; 356(2):160-165. PubMed ID: 28483447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular signal transduction of the hypoxia response.
    Nakayama K
    J Biochem; 2009 Dec; 146(6):757-65. PubMed ID: 19864435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF hydroxylase inhibitors decrease cellular oxygen consumption depending on their selectivity.
    Sulser P; Pickel C; Günter J; Leissing TM; Crean D; Schofield CJ; Wenger RH; Scholz CC
    FASEB J; 2020 Feb; 34(2):2344-2358. PubMed ID: 31908020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF-prolyl hydroxylases and cardiovascular diseases.
    Sen Banerjee S; Thirunavukkarasu M; Tipu Rishi M; Sanchez JA; Maulik N; Maulik G
    Toxicol Mech Methods; 2012 Jun; 22(5):347-58. PubMed ID: 22424133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolyl hydroxylase inhibitor treatment confers whole-animal hypoxia tolerance.
    Kasiganesan H; Sridharan V; Wright G
    Acta Physiol (Oxf); 2007 Jun; 190(2):163-9. PubMed ID: 17394573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathway.
    Shin J; Nunomiya A; Kitajima Y; Dan T; Miyata T; Nagatomi R
    Skelet Muscle; 2016; 6():5. PubMed ID: 26949511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Things get broken: the hypoxia-inducible factor prolyl hydroxylases in ischemic heart disease.
    Schreiber T; Salhöfer L; Quinting T; Fandrey J
    Basic Res Cardiol; 2019 Mar; 114(3):16. PubMed ID: 30859331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-inducible factor prolyl-4-hydroxylase-1 is a convergent point in the reciprocal negative regulation of NF-κB and p53 signaling pathways.
    Ullah K; Rosendahl AH; Izzi V; Bergmann U; Pihlajaniemi T; Mäki JM; Myllyharju J
    Sci Rep; 2017 Dec; 7(1):17220. PubMed ID: 29222481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment of hypoxia-induced HIF-1α signaling in keratinocytes and fibroblasts by sulfur mustard is counteracted by a selective PHD-2 inhibitor.
    Deppe J; Popp T; Egea V; Steinritz D; Schmidt A; Thiermann H; Weber C; Ries C
    Arch Toxicol; 2016 May; 90(5):1141-50. PubMed ID: 26082309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Hypoxia-Inducible Factor-1 (HIF-1) and Regulatory Prolyl Hydroxylase (PHD) Enzymes Following Hypoxic-Ischemic Injury in the Neonatal Rat.
    Chu HX; Jones NM
    Neurochem Res; 2016 Mar; 41(3):515-22. PubMed ID: 26108712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF prolyl hydroxylase-3 mediates alpha-ketoglutarate-induced apoptosis and tumor suppression.
    Tennant DA; Gottlieb E
    J Mol Med (Berl); 2010 Aug; 88(8):839-49. PubMed ID: 20383689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.